Created: 11/23/2013 8:19 AM WDIO.com
WASHINGTON (AP) — U.S. regulators have approved a new drug from Johnson & Johnson for use in treating chronic hepatitis C infections.
The Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.
The Johnson & Johnson drug is designed to eliminate hepatitis C, the most common form of the liver-destroying virus. It is a daily pill taken in combination with the long-established drug cocktail used to treat the most common form of the virus.
More than 3 million people in the U.S. have hepatitis C, a blood-borne disease that is blamed for 15,000 deaths a year.
Johnson & Johnson is one of a half-dozen companies working to develop more effective treatments for the virus as it threatens to become a major health epidemic among baby boomers and middle-age Americans.
People born between 1945 and 1965 are five times more likely to have the virus than people of other age groups. Many of them contracted the virus by sharing needles or having sex with an infected person in their youth. The disease was also spread by blood transfusions before 1992, when blood banks began testing for the virus.
For the last 20 years, the standard treatment for hepatitis C has involved a grueling one-year regimen of pills and injections. These two antiviral drugs, known as ribavirin and interferon-alpha, cause flu-like side effects including nausea, diarrhea and muscle achiness. The introduction of new drugs from Merck and Vertex Pharmaceuticals in 2011 helped shorten the treatment period and boost cure rates as high as 75 percent.
Olysio appears to be slightly more effective than the standard of care, curing 80 percent of patients who had not previously been treated for the disease, according to studies submitted to the FDA.
More significantly, the drug helped most patients cut the amount of time they had to take the traditional drug cocktail to six months.
Additionally, members of the FDA's advisory panel said the drug's once-a-day dosage should be far more manageable for patients than the current drugs from Merck and Vertex, which require taking 12 pills or six pills a day, respectively.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Woman Charged with Murder after Stabbing in Stoney Brook Township
There is new development in the murder case on the Fond du Lac Reservation. The husband of the victim has been released, and he is facing no charges. Instead, the woman who police had been searching for, Lydia Marie Barney, has been charged with second degree murder.
NYC Tries to Ease Ebola Fear after Doctor Infected
Officials tried to tamp down New Yorkers' fears Friday after a doctor was diagnosed with Ebola in a city where millions of people squeeze into crowded subways, buses and elevators every day.
Minn. Officials Walk Through Mock Ebola Scenario
More than 100 representatives from several Minnesota agencies are going through a mock exercise to review the state's preparedness in the event of a case of Ebola.
No Injuries in Early Morning Esko Structure Fire
Deputies say there were no injuries in an early morning structure fire in Esko Thursday. Crews responded to the 200 block of Nelson Road around 4:30 a.m. Deputies said the cause of the fire was not suspicious.
1 Dead, 1 Arrested in Cass County Crash
An Aitkin County man is in custody and another person is dead after a two-vehicle head-on collision in Cass County.